A

Apontis Pharma AG
XETRA:APPH

Watchlist Manager
Apontis Pharma AG
XETRA:APPH
Watchlist
Price: 9.64 EUR -1.43% Market Closed
Market Cap: 80.3m EUR
Have any thoughts about
Apontis Pharma AG?
Write Note

Apontis Pharma AG
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Apontis Pharma AG
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
A
Apontis Pharma AG
XETRA:APPH
Other Liabilities
€15.8m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Other Liabilities
$11.2m
CAGR 3-Years
80%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Other Liabilities
€13.7B
CAGR 3-Years
-10%
CAGR 5-Years
-4%
CAGR 10-Years
0%
Merck KGaA
XETRA:MRK
Other Liabilities
€2.5B
CAGR 3-Years
-13%
CAGR 5-Years
-11%
CAGR 10-Years
2%
Dermapharm Holding SE
XETRA:DMP
Other Liabilities
€143.6m
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Other Liabilities
€339k
CAGR 3-Years
101%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Apontis Pharma AG
Glance View

Market Cap
80.3m EUR
Industry
Pharmaceuticals

APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

APPH Intrinsic Value
15.03 EUR
Undervaluation 36%
Intrinsic Value
Price
A

See Also

What is Apontis Pharma AG's Other Liabilities?
Other Liabilities
15.8m EUR

Based on the financial report for Dec 31, 2023, Apontis Pharma AG's Other Liabilities amounts to 15.8m EUR.

What is Apontis Pharma AG's Other Liabilities growth rate?
Other Liabilities CAGR 3Y
26%

Over the last year, the Other Liabilities growth was 29%. The average annual Other Liabilities growth rates for Apontis Pharma AG have been 26% over the past three years .

Back to Top